Download to read offline
PPT, PDF265 views
Embracing Progress, Transforming Treatment, Empowering Patients: Harnessing the Potential of TROP2-Targeted ADC Therapy in TNBC and HR+, HER2- Breast Cancer
Chair and Presenter Komal Jhaveri, MD, FACP, and Ana C. Garrido-Castro, MD, discuss breast cancer in this CME/MOC/NCPD/AAPA activity titled “Embracing Progress, Transforming Treatment, Empowering Patients: Harnessing the Potential of TROP2-Targeted ADC Therapy in TNBC and HR+, HER2- Breast Cancer.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at https://bit.ly/3x5HWhG. CME/MOC/NCPD/AAPA credit will be available until September 23, 2025.
Related topics:
